A Study on the Therapeutic Alliance of Montelukast Sodium and Mycobacterium Phlei F.U.36 in Asthma of Young Children
- VernacularTitle:孟鲁司特钠和草分枝杆菌F.U.36治疗婴幼儿哮喘临床研究
- Author:
Yehong WANG
;
Huabin YANG
;
Xiaoling HE
- Publication Type:Journal Article
- Keywords:
Asthma;
Infant, young children;
Montelukast sodium;
Mycobacterium phlei F.U.36;
Therapy
- From:
Journal of Chinese Physician
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy of combination treatment of montelukast sodium (singulair TM ) plus mycobacterium phlei F.U.36 (wtilin"s") on young children with asthma.Methods 96 young children with asthma were randomly assigned into GroupⅠ:montelukast sodium (orally 2 5mg,q.n) plus mycobacterium phlei F.U.36 intramuscular injection for a total of 6 ampules,Group Ⅱ only montelukast sodium orally 2 5mg nightly and placebo Group.Participants were followed up for 12 weeks.Resuts Combined treatment of montelukast sodium and mycobacterium phlei F.U.36 was more effective to improve asthma in young children than the treatment with only monstelukast sodium.Conclusion The combination therapy of monkelukast and mycobacterium phlei F.U.36 is a highly effective method for preventing asthma attacks or controlling asthma.
